logo-loader
EnergyOil & Gas
Enquest Plc

EnQuest downgraded by Barclays amid concerns over complexity

Barclays set a new price target of 45p, down from 60p, which compares to a market price of 36.85p

oil and gas operations
Barclays says the recent rights issue was a 'necessary step'

EnQuest PLC (LON:ENQ) has been downgraded by analysts at Barclays, which no longer takes a positive view of what is described as an ‘overly complicated’ business.

Barclays described the North Sea oil firm’s recent £107mln rights issue as a “necessary step” in addressing near-term debt repayments and the Magnus acquisition payment.

READ: EnQuest buys rest of Magnus fields from BP

“However, the fact that it was necessary despite our prior estimates indicating otherwise highlights the sub-optimal nature of EnQuest's disclosures around what has become a complex operating and financial structure,” Barclays analysts said.

“Simplistically, EnQuest is a debt-levered North Sea oil producer that should be quickly paying down debt in the current macro environment.

“In reality, we forecast end-18E net debt being flat year-on-year at c$2.0bn as annual EBITDAX growth of c160% fails to translate into free cash flow.”

Barclays set a new price target of 45p, down from 60p, which compares to a market price of 36.85p.

“With other oil-levered producers appearing more attractive in our view, we downgrade the stock to ‘equal weight’ from ‘overweight’,” Barclays added.

Quick facts: Enquest Plc

Price: £0.21

Market: AIM
Market Cap: £349.65 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: CB2 Insights licenses electronic data capture software to UK...

CB2 Insights (CSE:CBII-OTCQB: CBIIF) CEO Prad Sekar joined Steve Darling from Proactive Vancouver to discuss the company doing a deal with MYACCESS Clinics. This will allow CB2’s software to capture comprehensive data sets related to patient health and treatment histories and manage ongoing...

15 hours, 21 minutes ago

RNS

Holding(s) in Company

3 days, 21 hours ago

Director/PDMR Shareholding

4 days, 21 hours ago

Director/PDMR Shareholding

1 week, 5 days ago

Chairman Succession

2 weeks, 2 days ago

Holding(s) in Company

2 weeks, 5 days ago

Total Voting Rights

3 weeks, 3 days ago

Total Voting Rights

on 29/7/19

2 min read